{"id":23640,"date":"2016-09-07T09:47:46","date_gmt":"2016-09-07T08:47:46","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=23640"},"modified":"2016-09-07T09:47:46","modified_gmt":"2016-09-07T08:47:46","slug":"situacions-especials-i-complicacions-en-el-pacient-diabetic","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","title":{"rendered":"Situacions especials i complicacions en el pacient diab\u00e8tic"},"content":{"rendered":"<p>La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, <b>pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. <\/b>A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides de diversos \u00f2rgans, especialment els ulls, els ronyons, els nervis, el cor i els vasos sanguinis. Per donar resposta a aquestes situacions, el farmac\u00e8utic ha de tenir la base cient\u00edfica que permet fer una intervenci\u00f3 efica\u00e7 tant a escala individual com col\u00b7lectiu per prevenir les possibles complicacions de la malaltia.<\/p>\n<p style=\"text-align: left;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-23647 aligncenter\" alt=\"curs-diabetis-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-1.jpg\" width=\"555\" height=\"291\" \/><\/a><br \/>\nEl primer semestre de l\u2019any, el COFB va programar un <b>curs per situacions especials i complicacions en el pacient diab\u00e8tics<\/b>. La formaci\u00f3 va comptar amb <b>Rosa Corcoy<\/b>, metgessa adjunta del Servei d\u2019Endocrinologia de l\u2019Hospital de Sant Pau i coordinadora de la cl\u00ednica d\u2019endocrinopatia i gestaci\u00f3; <b>Bel\u00e9n Dalama<\/b>, endocrin\u00f2loga del Servei d&#8217;Endocrinologia de Vall d\u2019Hebron especialitzada en el maneig del pacient diab\u00e8tic policomplicat; <b>Albert Goday<\/b>, cap de Secci\u00f3 d\u2019Endocrinologia del Parc Salut Mar, investigador del grup d\u2019investigaci\u00f3 en risc cardiovascular i nutrici\u00f3 del IMIM i organitzador del proper Congr\u00e9s de la Societat Catalana de Diabetis; i <b>Jordi Mesa<\/b>, cap d\u2019Endocrinologia de l\u2019Hospital de la Vall d\u2019Hebron.<\/p>\n<figure id=\"attachment_23645\" aria-describedby=\"caption-attachment-23645\" style=\"width: 268px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-2.jpg\"><img decoding=\"async\" class=\" wp-image-23645  \" alt=\"conferencia-diabetis-COFB-juny (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-2.jpg\" width=\"268\" height=\"179\" \/><\/a><figcaption id=\"caption-attachment-23645\" class=\"wp-caption-text\">Albert Goday, cap de Secci\u00f3 d\u2019Endocrinologia del Parc Salut Mar<\/figcaption><\/figure>\n<p>Com a cloenda del curs, i en obert per a tots els col\u00b7legiats, el 16 de juny va tenir lloc una <b>confer\u00e8ncia sobre perspectives de futur en diabetologia<\/b> a c\u00e0rrec d\u2019un dels docents del curs, Albert Goday. En aquesta confer\u00e8ncia es va parlar de l&#8217;evoluci\u00f3 en augment de la prevalen\u00e7a de la diabetis tipus 2 a Espanya -actualment un 13,79%-, prevalen\u00e7a m\u00e9s freq\u00fcent en dones fins els 75 anys, per despr\u00e9s invertir-se la tend\u00e8ncia i ser m\u00e9s prevalent en homes.<\/p>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_23648\" aria-describedby=\"caption-attachment-23648\" style=\"width: 298px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-2.jpg\"><img decoding=\"async\" class=\" wp-image-23648  \" alt=\"curs-diabetis-COFB (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-2.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-23648\" class=\"wp-caption-text\">Merc\u00e8 Barau durant la presentaci\u00f3 del curs, al mes de febrer<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<div class=\"box shadow\">Es varen repassar les diferents estrat\u00e8gies farmacol\u00f2giques per abordar la malaltia, fent m\u00e9s \u00e8mfasis en les m\u00e9s noves \u201ccom \u00e9s el cas de les <b>gliptines (inhibidors de la DPP4)<\/b> que potencien l&#8217;activitat de les incretines GLP1 i GIP sobre el p\u00e0ncrees en retardar la seva inactivaci\u00f3 sense produir hipogluc\u00e8mies, ni augment de pes; o els <b>agonistes del GLP1<\/b>, uns injectables que actuen sobre els factors que regulen la glucosa postpandrial estimulant l&#8217;alliberaci\u00f3 d\u2019insulina i disminuint la de glucag\u00f3, un d\u2019ells el <b>liraglutide<\/b>, \u00e9s un f\u00e0rmac que actualment es pot fer servir en el tractament de l&#8217;obesitat; i per \u00faltim, es va parlar de les <b>glifozines<\/b>, uns glucos\u00farics que actuen a nivell glom\u00e8rul renal bloquejant la reabsorci\u00f3 de glucosa i afavorint la seva excreci\u00f3 per l&#8217;orina, per\u00f2 s&#8217;ha d&#8217;anar amb cura perqu\u00e8 alhora incrementa el risc d&#8217;infeccions genito-urin\u00e0ries\u201d explica <b>Merc\u00e8 Barau, coordinadora del curs i anterior vocal de la Junta de Govern del COF Barcelona<\/b>.<\/div>\n<p>\u201cA la confer\u00e8ncia tamb\u00e9 es va recordar <b>que totes les guies de consens recomanen com a primer f\u00e0rmac d\u2019elecci\u00f3 la metformina<\/b>, es va fer un rep\u00e0s a les insulines i es varen comentar les noves que s\u2019han incorporat ara. Es van presentar els nous aparells per mesurar la glucosa, com el sensor continus que no necessiten punxar-se, o aparells per injectar-se insulina com s\u00f3n les bombes, i es va parlar de la cirurgia bari\u00e0trica i metab\u00f2lica com, de moment, l&#8217;\u00fanica estrat\u00e8gia per deixar de ser diab\u00e8tic,\u00a0comentant el trasplantament dels illots de les c\u00e8l\u00b7lules pancre\u00e0tiques com una l\u00ednia en qu\u00e8 seguir investigant\u201d comenta Barau. Per finalitzar, es van explicar quines s\u00f3n les noves dianes terap\u00e8utiques com les actuacions sobre la microbiota del budell o la grassa parda o la possibilitat de ter\u00e0pia g\u00e8nica.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-23646 aligncenter\" alt=\"conferencia-diabetis-COFB-juny (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-3.jpg\" width=\"593\" height=\"312\" \/><\/a><\/p>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><a href=\"http:\/\/www.janssen.com\/es\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-6780 alignright\" alt=\"janssen_logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/06\/janssen_logo.jpg\" width=\"100\" height=\"49\" \/><\/a><\/p>\n<p align=\"right\">\n","protected":false},"excerpt":{"rendered":"<p>La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,197,2465,2466],"class_list":["post-23640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-diabetis","tag-diabetologia","tag-pacient-diabetic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-07T08:47:46+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Situacions especials i complicacions en el pacient diab\u00e8tic\",\"datePublished\":\"2016-09-07T08:47:46+00:00\",\"dateModified\":\"2016-09-07T08:47:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"},\"wordCount\":704,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"diabetis\",\"diabetologia\",\"pacient diab\u00e8tic\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\",\"name\":\"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-09-07T08:47:46+00:00\",\"dateModified\":\"2016-09-07T08:47:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Situacions especials i complicacions en el pacient diab\u00e8tic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","og_locale":"ca_ES","og_type":"article","og_title":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-09-07T08:47:46+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Situacions especials i complicacions en el pacient diab\u00e8tic","datePublished":"2016-09-07T08:47:46+00:00","dateModified":"2016-09-07T08:47:46+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"},"wordCount":704,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","diabetis","diabetologia","pacient diab\u00e8tic"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","url":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","name":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-09-07T08:47:46+00:00","dateModified":"2016-09-07T08:47:46+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Situacions especials i complicacions en el pacient diab\u00e8tic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=23640"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/23640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=23640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=23640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=23640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}